In more recent years, Bai et al. found through computer-aided drug design screening that the introduction of amidic and sulfonamidic moieties not only maintains the interaction with the CXCR4 receptor, but also blocks the invasion of CXCR4-positive tumor cells (Figure 8). Here, CXCR4 is linked to neoplasm.